Malaria elimination in China: an eminent milestone in the anti-malaria campaign and challenges in the post-elimination stage

doi:10.12140/j.issn.1000-7423.2021.04.001

Abstract

Abstract:

Malaria is one of the oldest and most severe infectious diseases in China. After over 70 years of comprehensive control and prevention measures, great achievements have been made in malaria control in China, with a remarkable decline in morbidity and mortality. The malaria epidemic has been controlled effectively, ensuring people’s health, reducing the poverty due to illness, and promoting social and economic development. The milestone achievements in elimination of indigenous malaria cases nationwide has been maintained for 4 consecutive years since 2017, and thereafter the World Health Organization certificated malaria elimination in China on June 30, 2021, which is a significant milestone in the public health in China and the global history of malaria elimination. This paper systematically reviews the great impacts, performance characteristic and experiences gained from malaria elimination program, and the challenges in post-elimination stage in China.

Key words: Malaria, Elimination, China, Milestone, Challenge

CLC Number:

R531.3

FENG Jun, ZHANG Li, XIA Zhi-gui, XIAO Ning. Malaria elimination in China: an eminent milestone in the anti-malaria campaign and challenges in the post-elimination stage[J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2021, 39(4): 421-428.

Figures/Tables 2

References 55

[1]	World Health Organization. World malaria report 2020[R]. Geneva: WHO, 2020: 16.
[2]	Tang LH. Chinese achievements in malaria control and research[J]. Chin J Parasitol Parasit Dis, 1999, 17(5):257-259. (in Chinese)
	(汤林华. 我国疟疾防治研究成就[J]. 中国寄生虫学与寄生虫病杂志, 1999, 17(5):257-259.)
[3]	National Health and Family Planning Commission. Mid-term evaluation of National Malaria Elimination Action Plan (2010—2020) [Z/OL]. (2016-09-01) [2021-07-30]. http://www.nhc.gov.cn/jkj/s5873/201609/3ded209757704ab4871536ca-74716661.shtml.(in Chinese)
	(国家卫生与计划生育委员会. 关于印发《〈中国消除疟疾行动计划(2010—2020年)〉中期评估报告》的通知[Z/OL]. (2016-09-01)[2021-07-30]. http://www.nhc.gov.cn/jkj/s5873/201609/3ded209757704ab4871536ca-74716661.shtml.)
[4]	Zhou SS, Wang Y, Li Y. Malaria situation in the People’s republic of China in 2010[J]. Chin J Parasitol Parasit Dis, 2011, 29(6):401-403. (in Chinese)
	(周水森, 王漪, 李雨. 2010年全国疟疾疫情分析[J]. 中国寄生虫学与寄生虫病杂志, 2011, 29(6):401-403.)
[5]	Xia ZG, Yang MN, Zhou SS. Malaria situation in the People’s republic of China in 2011[J]. Chin J Parasitol Parasit Dis, 2012, 30(6):419-422. (in Chinese)
	(夏志贵, 杨曼尼, 周水森. 2011年全国疟疾疫情分析[J]. 中国寄生虫学与寄生虫病杂志, 2012, 30(6):419-422.)
[6]	Zhang L, Feng J, Zhang SS, et al. The progress of national malaria elimination and epidemiological characteristics of malaria in China in 2017[J]. Chin J Parasitol Parasit Dis, 2018, 36(3):201-209. (in Chinese)
	(张丽, 丰俊, 张少森, 等. 2017年全国消除疟疾进展及疫情特征分析[J]. 中国寄生虫学与寄生虫病杂志, 2018, 36(3):201-209.)
[7]	Feng J, Zhang L, Huang F, et al. Ready for malaria elimination: zero indigenous case reported in the People’s Republic of China[J]. Malar J, 2018, 17:315. doi: 10.1186/s12936-018-2444-9
[8]	Feng J, Zhou SS. From control to elimination: the historical retrospect of malaria control and prevention in China[J]. Chin J Parasitol Parasit Dis, 2019, 37(5):505-513. (in Chinese)
	(丰俊, 周水森. 从控制走向消除: 我国疟疾防控的历史回顾[J]. 中国寄生虫学与寄生虫病杂志, 2019, 37(5):505-513.)
[9]	Feng J, Zhang L, Xia ZG, et al. Malaria-free certification in China: achievements and lessons learned from the National Malaria Elimination Programme[J]. Zoonoses, 2021, 1:3-6.
[10]	Qian HL, Tang LH. The achievements and prospects on malaria control and prevention for 50 years in China[J]. Chin J Epidemiol, 2000, 21(3):225-227. (in Chinese) pmid: 15460009
	(钱会霖, 汤林华. 中国五十年疟疾防治工作的成就与展望[J]. 中华流行病学杂志, 2000, 21(3):225-227.) pmid: 15460009
[11]	Zhou SS, Wang Y, Xia ZG. Malaria situation in the People’s Republic of China in 2009[J]. Chin J Parasitol Parasit Dis, 2011, 29(1):1-3. (in Chinese)
	(周水森, 王漪, 夏志贵. 2009年全国疟疾疫情分析[J]. 中国寄生虫学与寄生虫病杂志, 2011, 29(1):1-3.)
[12]	The Ministry of Health. National Malaria Elimination Action Plan (2010—2020) [Z/OL]. (2010-05-26) [2021-07-30]. http://www.moh.gov.cn/mohjbyfkzj/s3593/201005/47529.shtml.(in Chinese)
	(中华人民共和国卫生部. 关于印发《中国消除疟疾行动计划(2010—2020年)》的通知[Z/OL]. (2010-05-26) [2021-07-30]. http://www.moh.gov.cn/mohjbyfkzj/s3593/201005/47529.shtml.)
[13]	Tang LH. The key strategy to eliminate malaria in China: case-based clues to track, remove the epidemic foci and eliminate the infection source[J]. China Trop Med, 2017, 17(5):431-434. (in Chinese)
	(汤林华. 我国消除疟疾的关键策略: 线索追踪, 清点拔源[J]. 中国热带医学, 2017, 17(5):431-434.)
[14]	Cao J, Sturrock HJW, Cotter C, et al. Communicating and monitoring surveillance and response activities for malaria elimination: China’s “1-3-7” strategy[J]. PLoS Med, 2014, 11(5):e1001642. doi: 10.1371/journal.pmed.1001642
[15]	World Health Organization. From 30 million cases to zero: China is certified malaria-free by WHO[EB/OL]. (2021-06-30) [2021-07-30]. https://www.who.int/news/item/30-06-2021-from-30-million-cases-to-zero-china-is-certified-malaria-free-by-who.
[16]	Feng J, Tu H, Zhang L, et al. Mapping transmission foci to eliminate malaria in the People’s Republic of China, 2010—2015: a retrospective analysis[J]. BMC Infect Dis, 2018, 18(1):115. doi: 10.1186/s12879-018-3018-8 pmid: 29514598
[17]	Zhang L, Feng J, Zhang SS, et al. Malaria situation in the People’s Republic of China in 2016[J]. Chin J Parasitol Parasit Dis, 2017, 35(6):515-519. (in Chinese)
	(张丽, 丰俊, 张少森, 等. 2016年全国疟疾疫情分析[J]. 中国寄生虫学与寄生虫病杂志, 2017, 35(6):515-519.)
[18]	Zhang L, Feng J, Zhang SS, et al. Epidemiological characteristics of malaria and the progress towards its elimination in China in 2018[J]. Chin J Parasitol Parasit Dis, 2019, 37(3):241-247. (in Chinese)
	(张丽, 丰俊, 张少森, 等. 2018年全国疟疾疫情特征及消除工作进展[J]. 中国寄生虫学与寄生虫病杂志, 2019, 37(3):241-247.)
[19]	Zhang L, Feng J, Xia ZG, et al. Epidemiological characteristics of malaria and progress on its elimination in China in 2019[J]. Chin J Parasitol Parasit Dis, 2020, 38(2):133-138. (in Chinese)
	(张丽, 丰俊, 夏志贵, 等. 2019年全国疟疾疫情特征分析及消除工作进展[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(2):133-138.)
[20]	Zhang L, Feng J, Tu H, et al. Malaria epidemiology in China in 2020[J]. Chin J Parasitol Parasit Dis, 2021, 39(2):195-199. (in Chinese)
	(张丽, 丰俊, 涂宏, 等. 2020年全国疟疾疫情分析[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(2):195-199.)
[21]	Zhang L, Feng J, Xia ZG. Malaria situation in the People’s Republic of China in 2013[J]. Chin J Parasitol Parasit Dis, 2014, 32(6):407-413. (in Chinese)
	(张丽, 丰俊, 夏志贵. 2013年全国疟疾疫情分析[J]. 中国寄生虫学与寄生虫病杂志, 2014, 32(6):407-413.)
[22]	Zhang L, Zhou SS, Feng J, et al. Malaria situation in the people’s Republic of China in 2014[J]. Chin J Parasitol Parasit Dis, 2015, 33(5):319-326. (in Chinese)
	(张丽, 周水森, 丰俊, 等. 2014年全国疟疾疫情分析[J]. 中国寄生虫学与寄生虫病杂志, 2015, 33(5):319-326.)
[23]	Zhang L, Feng J, Zhang SS, et al. Malaria situation in the People’s republic of China in 2015[J]. Chin J Parasitol Parasit Dis, 2016, 34(6):477-481. (in Chinese)
	(张丽, 丰俊, 张少森, 等. 2015年全国疟疾疫情分析[J]. 中国寄生虫学与寄生虫病杂志, 2016, 34(6):477-481.)
[24]	Bureau of Disease Control and Prevention, National Health Commission. China is certified malaria-free by World Health Organization[EB/OL]. (2021-06-30) [2021-07-30]. http://www.nhc.gov.cn/jkj/s5874/202106/cffeb8ba568c4939a7e72668dd446d4c.shtml.(in Chinese)
	(中华人民共和国国家卫生健康委疾病预防控制局. 中国顺利通过世界卫生组织消除疟疾认证[EB/OL]. (2021-06-30) [2021-07-30]. http://www.nhc.gov.cn/jkj/s5874/202106/cffeb8ba568c4939a7e72668dd446d4c.shtml)
[25]	Yin JH, Yan H, Huang F, et al. Establishing a China malaria diagnosis reference laboratory network for malaria elimination[J]. Malar J, 2015, 14(1):1-7. doi: 10.1186/1475-2875-14-1
[26]	WU XR. Analysis on the function and significance of joint malaria prevention in 5 Provinces[J]. Hubei J Prev Med, 1995, 6(2):1-8. (in Chinese).
	(吴兴荣. 5省疟疾联防的作用与意义浅析[J]. 湖北预防医学杂志, 1995, 6(2):1-8.)
[27]	Bureau of Disease Control and Prevention, National Health Commission. Strengthen the Standardized Management and Supervision of Malaria Elimination[Z/OL]. (2018-05-10) [2021-07-30]. http://www.nhc.gov.cn/jkj/s7929/201805/18-95c41ba7d645ec8b338c6582152417.shtml.(in Chinese)
	(中华人民共和国国家卫生健康委疾病预防控制局. 关于加强消除疟疾规范管理和督导检查工作的通知[Z/OL]. (2018-05-10)[2021-07-30]. http://www.nhc.gov.cn/jkj/s7929/201805/18-95c41ba7d645ec8b338c6582152417.shtml.)
[28]	Feng J, Liu J, Feng X, et al. Towards malaria elimination: monitoring and evaluation of the “1-3-7” approach at the China-Myanmar border[J]. Am J Trop Med Hyg, 2016, 95(4):806-810. doi: 10.4269/ajtmh.15-0888
[29]	Kheang ST, Sovannaroth S, Barat LM, et al. Malaria elimination using the 1-3-7 approach: lessons from Sampov Loun, Cambodia[J]. BMC Public Health, 2020, 20:544. doi: 10.1186/s12889-020-08634-4 pmid: 32321475
[30]	Aung PP, Thein ZW, Hein ZNM, et al. Challenges in early phase of implementing the 1-3-7 surveillance and response approach in malaria elimination setting: a field study from Myanmar[J]. Infect Dis Poverty, 2020, 9:18. doi: 10.1186/s40249-020-0632-7 pmid: 32036792
[31]	Feng J, Zhang L, Tu H, et al. From elimination to post-elimination: characteristics, challenges and re-transmission preventing strategy of imported malaria in China[J]. China Trop Med, 2021, 21(1):5-10. (in Chinese)
	(丰俊, 张丽, 涂宏, 等. 从消除到消除后: 中国输入性疟疾的疫情特征、挑战及防止再传播策略[J]. 中国热带医学, 2021, 21(1):5-10.)
[32]	Pan B, Pei FQ, Ruan CW, et al. Diagnosis and treatment of the first imported case of Plasmodium knowlesi infection in China[J]. Chin J Parasitol Parasit Dis, 2016, 34(6):513-516. (in Chinese)
	(潘波, 裴福全, 阮彩文, 等. 我国首例输入性诺氏疟原虫感染现症病例的诊断和治疗[J]. 中国寄生虫学与寄生虫病杂志, 2016, 34(6):513-516.)
[33]	Zhou RM, Li SH, Gao LJ, et al. Diagnosis and analysis of the first imported case of Plasmodium knowlesi infection in Henan Province[J]. J Zhengzhou Univ Med Sci, 2018, 53(5):610-613. (in Chinese)
	(周瑞敏, 李素华, 高丽君, 等. 河南省首例输入性诺氏疟的诊断和分析[J]. 郑州大学学报(医学版), 2018, 53(5):610-613.)
[34]	Tang LH, Xu LQ, Chen YD. Parasitic disease control and research in China[M]. Beijing: Beijing Science & Technology Press, 2012: 120. (in Chinese).
	(汤林华, 许隆祺, 陈颖丹. 中国寄生虫病防治与研究[M]. 北京: 北京科学技术出版社, 2012: 120.)
[35]	Wang JG, Xu CC, Wong YK, et al. Artemisinin, the magic drug discovered from traditional Chinese medicine[J]. Engineering, 2019, 5(1):32-39.
[36]	Pan B, Yang WS, Wu XG, et al. Field Evaluation of bednets impregnated with cyfluthrin for the control of malaria transmitted by Anopheles sinensis[J]. Chin J Parasit Dis Con, 2001, 14(3):165-167. (in Chinese)
	(潘波, 阳文胜, 吴旭光, 等. 氟氯氰菊酯浸泡蚊帐防制中华按蚊及防疟效果的现场评价[J]. 中国寄生虫病防治杂志, 2001, 14(3):165-167.)
[37]	Wang DQ, Chaki P, Mlacha Y, et al. Application of community-based and integrated strategy to reduce malaria disease burden in southern Tanzania: the study protocol of China-UK-Tanzania pilot project on malaria control[J]. Infect Dis Poverty, 2019, 8:4. doi: 10.1186/s40249-018-0507-3
[38]	Huang LL, Ding W, Shi DD, et al. Analysis of demands for trainings related to malaria control in Asia-Pacific countries[J]. Chin J Parasitol Parasit Dis, 2020, 38(3):350-353. (in Chinese)
	(黄璐璐, 丁玮, 施丹丹, 等. 亚太地区国家疟疾防控培训需求分析[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(3):350-353.)
[39]	Wang Q, Wang J, Li TT, et al. Analysis of demands of African students for China-Africa malaria prevention training[J]. Chin J Schisto Control, 2016, 28(4):461-464. (in Chinese)
	(王琦, 王玠, 李侗桐, 等. 非洲学员对我国援非疟疾防治培训的需求分析[J]. 中国血吸虫病防治杂志, 2016, 28(4):461-464.)
[40]	Julie A, Jessica J, Mwinyi M, et al. Perception of malaria risk in a setting of reduced malaria transmission: a qualitative study in Zanzibar[J]. Malar J, 2013, 12:75. doi: 10.1186/1475-2875-12-75
[41]	Espinoza JL. Malaria resurgence in the americas: an underestimated threat[J]. Pathogens, 2019, 8(1):11. doi: 10.3390/pathogens8010011
[42]	Feng J, Tu H, Zhang L, et al. Imported malaria cases: China, 2012—2018[J]. CCDC Weekly, 2020, 2(17):277-284.
[43]	Feng J, Xia ZG. Analysis of trends in cases of malaria reported from 2004 to July 2013 in the People’s Republic of China[J]. J Pathog Biol, 2014, 9(5):442-446. (in Chinese)
	(丰俊, 夏志贵. 2004—2013年中国疟疾发病情况及趋势分析[J]. 中国病原生物学杂志, 2014, 9(5):442-446.)
[44]	Feng J, Xia ZG, Vong S, et al. Preparedness for malaria resurgence in China: case study on imported cases in 2000—2012[J]. Adv Parasitol, 2014, 86:231-265.
[45]	Feng J, Zhang L, Zhang SS, et al. Malaria epidemiological characteristics in China, 2005—2015[J]. Chin Trop Med, 2017, 17(4):325-335. (in Chinese)
	(丰俊, 张丽, 张少森, 等. 全国2005—2015年疟疾疫情分析[J]. 中国热带医学, 2017, 17(4):325-335.)
[46]	Feng J, Xiao HH, Xia ZG, et al. Analysis of malaria epidemiological characteristics in the People’s Republic of China, 2004—2013[J]. Am J Trop Med Hyg, 2015, 93(2):293-299.
[47]	Lin KM, Li J, Yang YC, et al. Characteristics of imported malaria epidemic in Guangxi, 2013[J]. Mod Prev Med, 2015, 42(13):2439-2442. (in Chinese)
	(林康明, 黎军, 杨益超, 等. 2013年广西输入性疟疾疫情特征分析[J]. 现代预防医学, 2015, 42(13):2439-2442.)
[48]	Lin CY, Chen Z, Wang SQ, et al. Investigation of a rare local epidemic of Plasmodium malariae infection in Sanya City, Hainan Province[J]. Chin Trop Med, 2016, 16(5):481-484. (in Chinese)
	(林常勇, 陈朱, 王善青, 等. 海南省三亚市一起罕见的当地三日疟疫情分析及处置[J]. 中国热带医学, 2016, 16(5):481-484.)
[49]	Sun YW, Yu DM, Chen J, et al. Two individual incidences of vivax malaria in Dandong municipality of Liaoning Province[J]. Chin J Public Health, 2017, 33(2):314-316. (in Chinese)
	(孙英伟, 于丹梅, 陈君, 等. 辽宁省丹东市两例间日疟病例报告疫情分析[J]. 中国公共卫生, 2017, 33(2):314-316.)
[50]	Zhang Q, Geng QB, Sun JL, et al. Epidemiological analysis of the deaths of malaria in China, 2005—2014[J]. Chin J Prev Med, 2016, 50(4):302-305. (in Chinese).
	(张倩, 耿启彬, 孙军玲, 等. 2005—2014年中国疟疾死亡病例流行特征分析[J]. 中华预防医学杂志, 2016, 50(4) : 302-305.)
[51]	Zhang L, Tu H, Zhou SS, et al. Malaria deaths--China, 2011—2020[J]. CCDC Weekly, 2021, 3(17):360-365.
[52]	Feng J, Li J, Yan H, et al. Evaluation of antimalarial resistance marker polymorphism in returned migrant workers in China[J]. Antimicrob Agents Chemother, 2015, 59(1):326-330.
[53]	Feng J, Kong XL, Xu DM, et al. Investigation and evaluation of genetic diversity of Plasmodium falciparum Kelch 13 polymorphisms imported from Southeast Asia and Africa in southern China[J]. Front Public Health, 2019, 7:95.
[54]	Yan H, Kong XL, Zhang T, et al. Prevalence of Plasmodium falciparum kelch 13 (PfK13) and ubiquitin-specific protease 1 (pfubp1) gene polymorphisms in returning travelers from Africa reported in Eastern China[J]. Antimicrob Agents Chemother, 2020, 64(11):e00981-20.
[55]	Feng J, Xu DM, Kong XL, et al. Characterization of pfmdr1, pfcrt, pfK13, pfubp1, and pfap2mu in travelers returning from Africa with Plasmodium falciparum infections reported in China from 2014 to 2018[J]. Antimicrob Agents Chemother, 2021, 65(7):e0271720.